Tactile Medical Raises 2026 Adjusted EBITDA Outlook to $50 Million-$52 Million

Tactile Systems Technology Inc., which does business as Tactile Medical, raised its 2026 adjusted EBITDA outlook to $50 million-$52 million on Nov. 2, holding its revenue forecast steady after third-quarter revenue increased 7%. The revised adjusted EBITDA range is up from the company’s previous forecast of $49 million-$51 million. Tactile kept its full-year revenue outlook at $360 million-$366 million, a range that would represent growth of about 9%-11% from its 2025 revenue of $329.5 million. Adjusted EBITDA is a non-GAAP measure. Revenue for the quarter ended Sept.

Source: TokenPost